One year treatment with exenatide improves β cell function and glycaemic control in metformin treated type 2 diabetes patients

被引：0
|
作者：
Bunck, M. C.
Diamant, M.
Corner, A.
Eliasson, B.
Malloy, J. L.
Shaginian, R. M.
Deng, W.
Kendall, D. M.
Taskinen, M.-R.
Smith, U.
Yki-Jarvinen, H.
Heine, R. J.
机构：
[1] Vrije Univ Amsterdam, Dept Endocrinol, Med Ctr, Amsterdam, Netherlands
[2] Helsinki Univ Hosp, Dept Med, Helsinki, Finland
[3] Sahlgrens Univ Hosp, Lundberg Lab Diabet Res, S-41345 Gothenburg, Sweden
[4] Amylin Pharmaceut Inc, San Diego, CA USA
[5] Eli Lilly & Co, Houten, Netherlands
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0251
引用
收藏
页码：S111 / S112
页数：2
相关论文
共 50 条
  • [1] Treatment intensification with insulin degludec improves glycaemic control in patients with Type 2 diabetes treated with liraglutide and metformin
    Kumar, S.
    Aroda, V.
    Bailey, T.
    Cariou, B.
    Leiter, L.
    Raskin, P.
    Zacho, J.
    Philis-Tsimikas, A.
    [J]. DIABETIC MEDICINE, 2015, 32 : 66 - 66
  • [2] One-year exenatide treatment improves beta cell response in metformin treated patients with type 2 diabetes which is sustained after 5 weeks discontinuation of treatment
    Bunck, M. C.
    Mari, A.
    Corner, A.
    Eliasson, B.
    Shaginian, R. M.
    Wu, Y.
    Yan, P.
    Heine, R. J.
    Smith, U.
    Taskinen, M. -R.
    Yki-Jarvinen, H.
    Diamant, M.
    [J]. DIABETOLOGIA, 2009, 52 : S7 - S7
  • [3] One-year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients A randomized, controlled trial
    Bunck, Mathijs C.
    Diamant, Michaela
    Corner, Anja
    Eliasson, Bjorn
    Malloy, Jaret L.
    Shaginian, Rimma M.
    Deng, Wei
    Kendall, David M.
    Taskinen, Marja-Riitta
    Smith, Ulf
    Yki-Jarvinen, Hannele
    Heine, Robert J.
    [J]. DIABETES CARE, 2009, 32 (05) : 762 - 768
  • [4] Exenatide improves postprandial hyperglycaemia and dyslipidaemia in metformin treated patients with type 2 diabetes
    Bunck, M. C.
    Corner, A.
    Diamant, M.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    Taskinen, M. R.
    [J]. DIABETOLOGIA, 2008, 51 : S351 - S351
  • [5] Exenatide improves postprandial hyperglycemia and dyslipidemia in metformin treated patients with type 2 diabetes
    Bunck, Mathijs C.
    Corner, Anja
    Diamant, Michaela
    Eliasson, Bjorn
    Malloy, Jaret L.
    Shaginian, Rimma M.
    Ding, Wei
    Kendall, David M.
    Smith, Ulf
    Yki-Jarvinen, Hannele
    Heine, Robert J.
    Taskinen, Marja-Ritta
    [J]. DIABETES, 2008, 57 : A33 - A33
  • [6] Exenatide: One year of treatment improves beta-cell function in type 2 diabetics
    Sauvanet, J. -P.
    [J]. ANNALES D ENDOCRINOLOGIE, 2007, 68 (06)
  • [7] Mathematical modeling shows exenatide improved β-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea
    Mari, A.
    Nielsen, L. L.
    Nanayakkara, N.
    DeFronz, R. A.
    Ferrannini, E.
    Halseth, A.
    [J]. HORMONE AND METABOLIC RESEARCH, 2006, 38 (12) : 838 - 844
  • [8] Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes
    Derosa, G.
    Franzetti, I. G.
    Querci, F.
    Carbone, A.
    Ciccarelli, L.
    Piccinni, M. N.
    Fogari, E.
    Maffioli, P.
    [J]. DIABETIC MEDICINE, 2012, 29 (12) : 1515 - 1523
  • [9] Beta cell function and glycaemic control following one year exenatide therapy, and after 12 week wash-out, in patients with type 2 diabetes
    Corner, A.
    Bunck, M. C.
    Diamant, M.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Taskinen, M. R.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    [J]. DIABETOLOGIA, 2008, 51 : S351 - S351
  • [10] Miglitol combined with metformin improves glycaemic control in type 2 diabetes
    Van Gaal, L
    Maislos, M
    Schernthaner, G
    Rybka, J
    Segal, P
    [J]. DIABETES OBESITY & METABOLISM, 2001, 3 (05): : 326 - 331
12345